Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Thomas Jefferson University
City of Hope Medical Center
NRG Oncology
NRG Oncology
University of Washington
City of Hope Medical Center
Mayo Clinic
Jonsson Comprehensive Cancer Center
NRG Oncology
University of Southern California
Northwestern University
National Cancer Institute (NCI)